NCT03770013View on ClinicalTrials.gov

Dexmedetomidine Versus Clonidine for Transversus Abdominis Plane Block in Patients Undergoing Elective Caesarean Section

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

August 1, 2020

Conditions
Postoperative Pain
Interventions
DRUG

bupivacaine

bupivacaine 0.25% a total volume of 40 ml (20 ml each side

DRUG

Dexmedetomidine

Dexmedetomidine 0.5 mcg/kg

DRUG

clonidine

1ug/kg clonidine

DRUG

placebo

add placebo 9normal saline)

Trial Locations (1)

81528

Aswan University, Aswān

All Listed Sponsors
lead

Aswan University Hospital

OTHER

NCT03770013 - Dexmedetomidine Versus Clonidine for Transversus Abdominis Plane Block in Patients Undergoing Elective Caesarean Section | Biotech Hunter | Biotech Hunter